Geovax Labs Stock Current Valuation
| GOVX Stock | USD 1.44 0.04 2.70% |
Valuation analysis of GeoVax Labs helps investors to measure GeoVax Labs' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -0.33 in 2025. Enterprise Value Multiple is likely to drop to -0.33 in 2025. Fundamental drivers impacting GeoVax Labs' valuation include:
Undervalued
Today
Please note that GeoVax Labs' price fluctuation is relatively risky at this time. Calculation of the real value of GeoVax Labs is based on 3 months time horizon. Increasing GeoVax Labs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GeoVax Labs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GeoVax Stock. However, GeoVax Labs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.44 | Real 4.72 | Target 14.6 | Hype 1.35 | Naive 1.37 |
The intrinsic value of GeoVax Labs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GeoVax Labs' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GeoVax Labs helps investors to forecast how GeoVax stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GeoVax Labs more accurately as focusing exclusively on GeoVax Labs' fundamentals will not take into account other important factors: GeoVax Labs Company Current Valuation Analysis
GeoVax Labs' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GeoVax Labs Current Valuation | 12.17 M |
Most of GeoVax Labs' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GeoVax Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GeoVax Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for GeoVax Labs is extremely important. It helps to project a fair market value of GeoVax Stock properly, considering its historical fundamentals such as Current Valuation. Since GeoVax Labs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GeoVax Labs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GeoVax Labs' interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, GeoVax Labs has a Current Valuation of 12.17 M. This is 99.92% lower than that of the Biotechnology sector and 99.74% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.93% higher than that of the company.
GeoVax Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GeoVax Labs' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GeoVax Labs could also be used in its relative valuation, which is a method of valuing GeoVax Labs by comparing valuation metrics of similar companies.GeoVax Labs is currently under evaluation in current valuation category among its peers.
GeoVax Labs Current Valuation Drivers
We derive many important indicators used in calculating different scores of GeoVax Labs from analyzing GeoVax Labs' financial statements. These drivers represent accounts that assess GeoVax Labs' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of GeoVax Labs' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 128.8M | 137.9M | 24.0M | 13.8M | 15.8M | 15.0M | |
| Enterprise Value | 119.1M | 126.5M | (3.6M) | 7.3M | 8.4M | 8.0M |
GeoVax Fundamentals
| Return On Equity | -2.76 | ||||
| Return On Asset | -1.12 | ||||
| Operating Margin | (2.10) % | ||||
| Current Valuation | 12.17 M | ||||
| Shares Outstanding | 9.44 M | ||||
| Shares Owned By Insiders | 0.47 % | ||||
| Shares Owned By Institutions | 8.32 % | ||||
| Number Of Shares Shorted | 762.64 K | ||||
| Price To Earning | (1.25) X | ||||
| Price To Book | 1.60 X | ||||
| Price To Sales | 4.40 X | ||||
| Gross Profit | (19.25 M) | ||||
| EBITDA | (26.67 M) | ||||
| Net Income | (25.97 M) | ||||
| Cash And Equivalents | 30.9 M | ||||
| Cash Per Share | 1.25 X | ||||
| Total Debt | 3.52 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 9.51 X | ||||
| Book Value Per Share | 0.99 X | ||||
| Cash Flow From Operations | (25.17 M) | ||||
| Short Ratio | 1.39 X | ||||
| Earnings Per Share | (8.39) X | ||||
| Target Price | 14.6 | ||||
| Number Of Employees | 17 | ||||
| Beta | 3.29 | ||||
| Market Capitalization | 13.59 M | ||||
| Total Asset | 9.28 M | ||||
| Retained Earnings | (104.36 M) | ||||
| Working Capital | 4.37 M | ||||
| Current Asset | 1.24 M | ||||
| Current Liabilities | 126.99 K | ||||
| Net Asset | 9.28 M |
About GeoVax Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GeoVax Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeoVax Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeoVax Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.